The Nordic region is punching well above its weight in terms of pipeline size, numbers of companies and clinical trials as well as fundraising activities, and the future for firms in Iceland, Finland and Norway, as well as the more established sectors in Denmark and Sweden, looks rosy.
That was the main message that came out of the recent annual Nordic Life Science Days (NLSDays) meeting organized in Copenhagen for the first time in its ten-year history